Hudson Bay Capital Management »

Avalo Therapeutics Ord shares owned by Hudson Bay Capital Management

Quarter-by-quarter ownership of Avalo Therapeutics Ord (AVTX) shares owned by Hudson Bay Capital Management from 13F filings

Historical chart of Hudson Bay Capital Management investment in Avalo Therapeutics Ord

Tip: Access up to 7 years of quarterly data

All positions including Avalo Therapeutics Ord held by Hudson Bay Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Avalo Therapeutics Ord by Hudson Bay Capital Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $305k 17k 18.16

More positions owned by Hudson Bay Capital Management

Tesla Motors Call Option (TSLA)
NVIDIA Corporation Call Option (NVDA)
Amazon Call Option (AMZN)
Advanced Micro Devices Call Option (AMD)
Palantir Technologies Cl A Put Option (PLTR)
Microsoft Corporation Call Option (MSFT)
Netflix Put Option (NFLX)
Berkshire Hathaway Inc Del Cl B New Call Option (BRK.B)
Apple Call Option (AAPL)
Alphabet Cap Stk Cl A Put Option (GOOGL)
Ishares Tr Russell 2000 Etf Put Option (IWM)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Flagstar Bank National Assoc Com New (FLG)
Dollar Tree Call Option (DLTR)
Boeing Company Call Option (BA)

View all positions for Hudson Bay Capital Management

Top funds holding Avalo Therapeutics Ord

BVF
OrbiMed Advisors
Nantahala Capital Management
Point72 Asset Management
Affinity Asset Advisors
Caligan Partners
Balyasny Asset Management
Vanguard Group
Silverarc Capital Management
RA Capital Management
Marshall Wace
Citadel Advisors
TCG Crossover Management
Commodore Capital
UBS Group

View all funds holding Avalo Therapeutics Ord